Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-03-20

FDA Approved: AGRYLIN — Supplemental Application (Takeda Pharmaceuticals America, Inc.)

View source ↗

Summary

FDA approved a supplemental NDA for AGRYLIN (anagrelide hydrochloride) by Takeda Pharmaceuticals America, Inc., representing an approved supplement to the exist…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AGRYLIN (ANAGRELIDE HYDROCHLORIDE)

Snippet

SUPPL AP for AGRYLIN (ANAGRELIDE HYDROCHLORIDE)